Olink (NASDAQ:OLK) increased by 2.8% after obtaining consent from the German antitrust office for the planned sale to Thermo Fisher (NYSE:TMO).

The German Federal Cartel Office approved the transaction on Monday, according to a appointment on the website of the German antitrust authority.

The approval came after Germany approved it antitrust authority moved assessment of $3.1 billion in sales to Thermo Fisher (TMO) Ifor Phase 2 review in February.

Last month, the UK’s Competition and Markets Authority launched the first phase of its review of the merger. The deadline for issuing a decision is July 8. In February, the CMA revealed for the first time that the agency was assessing Olink/Thermo.

In October, Thermo Fisher (TMO) agreed to acquire Swedish company Olink (OLK) for $26 per share.